MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation Current Ratio 2011-2026 | CO
Annual Current Ratio Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.34 | 2.25 | 2.17 | 8.64 | 9.42 | 2.54 | 6.83 | 6.24 | 5.18 | 4.81 | 4.55 | 2.84 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.42 | 2.17 | 4.82 |
Quarterly Current Ratio Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.34 | - | 2.29 | - | 2.25 | - | 2.21 | - | 2.17 | - | 2.12 | - | 2.09 | - | 2.13 | - | 2.14 | - | 2.15 | - | 1.55 | - | 1.57 | - | 1.58 | - | 1.59 | - | 1.6 | - | 1.63 | - | 1.66 | - | 1.73 | 1.73 | 1.71 | - | 1.99 | 2.15 | 3.1 | 3.19 | 3.29 | - | 3.33 |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.33 | 1.55 | 2.13 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
2.37 | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Co-Diagnostics
CODX
|
10.2 | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Danaher Corporation
DHR
|
5.19 | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
1.49 | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
BioNano Genomics
BNGO
|
1.86 | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
4.85 | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
IQVIA Holdings
IQV
|
1.29 | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
1.68 | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
3.15 | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
CareDx, Inc
CDNA
|
2.27 | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
Celcuity
CELC
|
1.89 | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
NeoGenomics
NEO
|
2.23 | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
National Research Corporation
NRC
|
1.67 | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Anixa Biosciences
ANIX
|
7.99 | $ 3.12 | - | $ 99.5 K | USA |
 |
Precipio
PRPO
|
4.93 | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Personalis
PSNL
|
4.02 | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
0.914 | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.35 | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.85 | $ 46.3 | 0.02 % | $ 1.86 B | USA |
 |
Illumina
ILMN
|
6.69 | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
1.87 | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 579.45 | -0.69 % | $ 221 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.79 | -3.54 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
1.27 | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.78 | $ 250.88 | -0.87 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 182.22 | -0.43 % | $ 15 B | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 31.72 | -1.34 % | $ 1.9 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.94 | $ 676.53 | -0.85 % | $ 55.8 B | USA |
 |
Lantheus Holdings
LNTH
|
2.22 | $ 66.55 | -0.91 % | $ 4.61 B | USA |